defi
3 min read
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Wire Report via Decrypt
2LAR Wire Desk (Decrypt)
Syndicated Wire Desk • Published 2026-10-20
🎧
2LAR Executive Audio Briefing
Listen to Audio Wire Breakdown
2LAR AI Audio Briefing
Listen to 60-Second Audio Report
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients....
Real-time digital asset intelligence report synthesized from live wire distributions covering global market trends, network protocol upgrades, and regulatory developments.
Original Wire Sourcing
Syndicated from Decrypt. Read the full original report at Decrypt Wire.